In the European Union, shortages, shortages and reduced availability of drugs are a real problem. The reasons for a drug shortage are manifold: production interruptions due to lack of active ingredients that come from China and India (around 80 percent), increased demand, supply chain collapse compounded by the COVID-19 pandemic. In Poland, the minister of health does not see the problem and claims that possible shortages of drugs in pharmacies may result from pharmacists not ordering them.
Pharmaceutical company Teva is the largest producer of generics in the world. It produces about 3,600 drugs. Almost 200 million peo...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].